Yield10 Bioscience Inc (YTEN.OQ)
16 Feb 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|60||2013||Chairman of the Board, Independent Director|
|58||2016||President, Chief Executive Officer, Director|
|60||2016||Chief Accounting Officer, Vice President - Finance|
|52||2016||Vice President - Planning and Communications|
|2016||Chief Science Officer, Vice President - Research|
- BRIEF-Yield10 Bioscience Announces Pricing Of $12.6 Mln Public Offering
- BRIEF-Yield10 Bioscience Grants Research License To Monsanto To Evaluate Two Novel Yield Traits In Soybean
- BRIEF-Yield10 Bioscience Announces Adjournment Of Special Meeting Of Stockholders
- BRIEF-Yield10 Bioscience posts Q3 loss $0.59/shr from continuing operations
- BRIEF-Yield10 Bioscience obtains confirmation of nonregulated status from USDA-APHIS for its genome-edited Camelina line